Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.47 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5228623 | 1.00 | TAS1R3 (0.47) | TAS1R3TAS1R1PTPN1FAAHCNR1 | |
| SCHEMBL454225 | 0.86 | F7 (0.44) | PTPN1CNR1CNR2PPARGPPARA | |
| SCHEMBL454223 | 0.86 | F7 (0.44) | PTPN1CNR1CNR2PPARGPPARA | |
| SCHEMBL8150368 | 0.85 | PPARG (0.49) | PTPN1FAAHPPARGPPARA | |
| SCHEMBL26497556 | 0.85 | CNR2 (0.44) | TAS1R3TAS1R1PTPN1FAAHCNR1 | |
| SCHEMBL8150365 | 0.85 | PPARG (0.49) | PTPN1FAAHPPARGPPARA | |
| SCHEMBL7115034 | 0.84 | TAS1R3 (0.46) | TAS1R3TAS1R1PTPN1FAAHCNR1 | |
| SCHEMBL31509214 | 0.84 | TAS1R3 (0.46) | TAS1R3TAS1R1PTPN1FAAHCNR1 | |
| SCHEMBL14681838 | 0.83 | PPARG (0.51) | PTPN1FAAHPPARGPPARA | |
| SCHEMBL11375282 | 0.82 | TAS1R3 (0.44) | TAS1R3TAS1R1PTPN1FAAHCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242534-A9 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-08-03 | — | — | US | disclosed |
| CN-103827486-B | Fluid discharge system | 汉高股份有限及两合公司 | 2018-11-16 | — | — | CN | disclosed |
| EP-1439001-B1 | Process for producing optically active epoxides | TOSOH CORP (JP) | 2007-07-25 | — | — | EP | disclosed |
| EP-1127616-B1 | Catalyst for asymmetric epoxidations of enones and process for producing optically active epoxide employing it | TOSOH CORP (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1366815-B1 | Catalyst for asymmetric epoxidations of enones and process for producing optically active epoxide employing it | TOSOH CORP (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6878835-B2 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2005-04-12 | — | — | US | disclosed |
| EP-1439001-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2004-07-21 | — | — | EP | disclosed |
| US-20040116721-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| US-6680275-B2 | COMPLEX OF OPTICALLY ACTIVE BINAPHTHOL, LANTHANUM TRIISOPROPOXIDE OXIDE, TRIPHENYLPHOSPHINE OXIDE AND CUMENE OR TERT-BUTYL HYDROPEROXIDE; OPTICAL PURITY; REACTIVITY; STABILITY | TOSOH CORPORATION (JP) | 2004-01-20 | — | — | US | disclosed |
| EP-1366815-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2003-12-03 | — | — | EP | disclosed |
| US-20010051737-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | TOSOH CORPORATION (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-1127616-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | Tosoh Corporation (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-6201123-B1 | FOR ASYMMETRIC EPOXIDATION OF ENONES; GIVES EPOXIDES HAVING AN ENHANCED OPTICAL PURITY | TECHNO POLYMER CO., LTD. (JP) | 2001-03-13 | — | — | US | disclosed |
| US-4226892-A | Flavoring with cycloaliphatic unsaturated ketones | FIRMENICH SA (CH) | 1980-10-07 | — | — | US | disclosed |
| US-4187863-A | Cycloaliphatic unsaturated ketones as odor and taste modifying agents in tobacco products | FIRMENICH SA (CH) | 1980-02-12 | — | — | US | disclosed |
| US-3975310-A | PERFUME | FIRMENICH S.A. (CH) | 1976-08-17 | — | — | US | disclosed |
| US-3931326-A | FLAVOR, TASTE, ODOR, PERFUMES | FIRMENICH SA (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051737-A1 | Catalyst for asymmetric epoxidation of enones and process for producing optically active epoxide employing it | SQLE, ENO1, GPX4 | TAS1R3 4850/4885TAS1R1 4875/4885PTPN1 3993/4885 |
| US-20230242534-A9 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF | CDK2, CDK5, CDK9 | TAS1R3 3763/4885TAS1R1 3840/4885PTPN1 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.